Viewing Study NCT04455594


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-28 @ 12:05 AM
Study NCT ID: NCT04455594
Status: UNKNOWN
Last Update Posted: 2020-07-02
First Post: 2020-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module